Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
OptiBiotix Health ( (GB:OPTI) ) has shared an update.
OptiBiotix Health plc has issued 358,772 options over new ordinary shares to Director Sofia Kolyda, with an exercise price of 11 pence per share. The options, which expire in 2035, are part of the company’s strategic initiatives to incentivize leadership and align with its commercial goals, particularly in securing significant revenue-generating partnerships for its SweetBiotix products.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, is a life sciences company focused on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food products and drinks, with a focus on areas such as obesity, cardiovascular health, and diabetes.
Average Trading Volume: 316,539
Technical Sentiment Signal: Sell
Current Market Cap: £11.62M
See more data about OPTI stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money